Incretin-Based- Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics

Abstrakt

The type 2 diabetes is estimating to affect 120 million people worldwide - and according to projections from the World Health Organization this number is expected to double over next to decades. Novel, cost-effective strategies are needed to reverse the global epidemic of obesity which is driving the increased occurence of type 2 diabetes and to less the burden of diabetic vascular complications.

In the current volume, Topics in Prevention, Treatment and Complications of Type 2 diabetes, experts in biology and medicine from four different continents contribute important information and cutting-edge scientific knowledge on a variety of topics relevant to the management and prevention of diabetes and related illnesses.